A new Energy Intelligence feature titled "Fusion Developer Lands DOE Loan for Medical Isotope Facility" reports on SHINE's $263 million conditional loan commitment from the US Department of Energy to complete Chrysalis, our Janesville facility set to become the world's largest medical isotope production plant. The piece situates Chrysalis within a broader industry debate over whether fusion companies should commercialize along the way — or hold out for grid-scale power.
‍
As our founder and CEO Greg Piefer tells Energy Intelligence, fusion technology is already making jet aircraft safer, hardening electronics bound for space, and — once Chrysalis comes online — producing up to 20 million doses of Mo-99 annually for American patients who currently depend on aging reactors abroad.

Each phase of our work funds the next, lowering the cost curve toward commercial fusion electricity.
‍
Fusion's value isn't waiting on the grid. SHINE is delivering it today.
‍
Read the full article here.